These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27825791)

  • 1. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate.
    García-Vicuña R; Martín-Martínez MA; Gonzalez-Crespo MR; Tornero-Molina J; Fernández-Nebro A; Blanco-García FJ; Blanco-Alonso R; Marsal-Barril S;
    Reumatol Clin; 2017; 13(3):127-138. PubMed ID: 27825791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
    Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
    Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study.
    Juan Mas A; Castañeda S; Cantero Santamaría JI; Baquero JL; Del Toro Santos FJ;
    Reumatol Clin (Engl Ed); 2019; 15(5):264-270. PubMed ID: 29289700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis.
    Tornero-Molina J; Alperi-López M; Castellví I; de Agustín-de Oro JJ; Escudero A; García-Vicuña R; González-Gay MÁ; Hidalgo C; Rubio E; Sanmartí R; Casamira N; Calvo-Alén J
    Reumatol Clin (Engl Ed); 2022 Jan; 18(1):33-41. PubMed ID: 35090610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis.
    Todoerti M; Maglione W; Bernero E; Bortoluzzi A; Colaci M; Galuppi E; Paolino S; Talarico R; Cutolo M; Ferri C; Trotta F; Bombardieri S; Montecucco CM; Sinigaglia L
    Reumatismo; 2013 Dec; 65(5):207-18. PubMed ID: 24399184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain.
    Alonso A; González CM; Ballina J; García Vivar ML; Gómez-Reino JJ; Marenco JL; Fernández-Nebro A; Ordás C; Cea-Calvo L; Arteaga MJ; Sanmartí R
    Reumatol Clin; 2015; 11(3):144-50. PubMed ID: 25022442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of methotrexate adherence in rheumatoid arthritis patients.
    De Cuyper E; De Gucht V; Maes S; Van Camp Y; De Clerck LS
    Clin Rheumatol; 2016 May; 35(5):1335-9. PubMed ID: 26781783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project.
    Tornero-Molina J; Andreu JL; Martín-Martínez MA; Corominas H; Pérez Venegas JJ; Román-Ivorra JA; Sánchez-Alonso F
    Reumatol Clin (Engl Ed); 2019; 15(6):338-342. PubMed ID: 29273497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
    Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
    Chinese Association of Rheumatology and Immunology Physicians
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methotrexate treatment of rheumatoid arthritis in Denmark].
    de Thurah A; Nørgaard M; Stengaard-Pedersen K
    Ugeskr Laeger; 2011 Sep; 173(36):2187-9. PubMed ID: 21893001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the use of methotrexate in psoriatic arthritis.
    Cañete JD; Ariza-Ariza R; Bustabad S; Delgado C; Fernández-Carballido C; García Llorente JF; Loza E; Montilla C; Naranjo A; Pinto JA; Queiro R; Ramírez J; Tornero-Molina J
    Reumatol Clin (Engl Ed); 2018; 14(4):183-190. PubMed ID: 29050840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the use of parenteral methotrexate in rheumatic diseases.
    Tornero Molina J; Calvo Alen J; Ballina J; Belmonte MÁ; Blanco FJ; Caracuel MÁ; Carbonell J; Corominas H; Chamizo E; Hidalgo C; Ivorra JR; Marenco JL; Moreno Muelas JV; Muñoz-Fernández S; Nolla JM; Pérez T; Sanmarti R; Trenor P; Urrego C; Vidal J; Rosas Gomez de Salazar J
    Reumatol Clin (Engl Ed); 2018; 14(3):142-149. PubMed ID: 28082032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review.
    Curtis JR; Bykerk VP; Aassi M; Schiff M
    J Rheumatol; 2016 Nov; 43(11):1997-2009. PubMed ID: 27803341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story.
    Malaviya AN
    Int J Rheum Dis; 2016 Sep; 19(9):844-51. PubMed ID: 27293066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
    Schiff MH; Sadowski P
    Rheumatol Int; 2017 Feb; 37(2):213-218. PubMed ID: 28012023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
    Burmester GR; Rigby WF; van Vollenhoven RF; Kay J; Rubbert-Roth A; Blanco R; Kadva A; Dimonaco S
    Ann Rheum Dis; 2017 Jul; 76(7):1279-1284. PubMed ID: 28389552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.